Tag: Colorectal
Search News
Dr Mirjana Efremova awarded £1m Cancer Research UK grant to decode bowel cancer’s plastic nature
14th December 2023
Congratulations to Dr Mirjana Efremova who has been awarded a £1m grant to use cutting-edge computational tools to study how bowel cancer adapts.
Read more
Breaking down language barriers in cancer
4th February 2022
Vinaya Srirangam Nadhamuni, Clinical Research Fellow at Barts Cancer Institute, Queen Mary University of London, has been working on a project to make information about screening programmes more accessible to minority ethnic groups in the UK.
Read more
Congratulations to Vinaya Srirangam Nadhamuni
22nd September 2020
BCI PhD student wins People’s Choice Award at thesis competition national final Congratulations to Vinaya Srirangam Nadhamuni, Clinical Research Fellow at Barts Cancer Institute (BCI), Queen Mary University of London, […]
Read more
IBD and bowel cancer
29th April 2019
April is Bowel Cancer Awareness Month. We recently spoke with Dr Kit Curtius about her work which focuses on understanding how normal tissues evolve to become cancerous, with a particular interest in gastrointestinal pre-malignancies such as inflammatory bowel disease.
Read more
‘Chromosomal Catastrophes’ in Colorectal Cancer
5th September 2018
Understanding how cancers develop and change over time is a big challenge. For obvious reasons, scientists can’t simply sit and watch a cancer growing in a person. Members of the Evolution and Cancer Laboratory at the BCI, including lead author Dr William Cross, were part of a collaborative team that set out to identify when particular genetic changes arise during bowel cancer development.
Read more
Uncovering the evolutionary history of IBD-associated colorectal cancer
11th July 2018
A team of researchers from the BCI, led by Prof Trevor Graham, Lead of the Evolution and Cancer Biology Laboratory, have reported the genetic events involved in the early development of bowel cancer in patients with inflammatory bowel disease (IBD). Such knowledge may be able to be exploited to design simple diagnostic tests to stratify patients with IBD at high risk of developing cancer.
Read more